Ordinary Adjustment | Solactive Global Big Pharma Index | Effective Date 5th February 2026
Solactive Global Big Pharma Index:
In the ordinary adjustment, the following composition will be implemented effective open 5th February 2026:
| ABBVIE INC |
| ALNYLAM PHARMACEUTICALS INC |
| AMGEN INC |
| ASTRAZENECA PLC-SPONS ADR |
| ELI LILLY & CO |
| GILEAD SCIENCES INC |
| GSK PLC-SPON ADR |
| JOHNSON & JOHNSON |
| MERCK & CO. INC. |
| NOVARTIS AG-SPONSORED ADR |
| NOVO-NORDISK A/S-SPONS ADR |
| PFIZER INC |
| ROCHE HOLDING AG |
| SANOFI-ADR |
| VERTEX PHARMACEUTICALS INC |